Both can increase: Blood sugar may go up in response to either of these medications.
Answered 3/13/2015
5.5k views
Diabetogenic prograf: Tacrolimus (Prograf) is known to be diabetogenic and as much as 20-25% of renal transplant recipients who did not have diabetes prior to transplant surgery develop post-transplant diabetes. Mycophenolate mofetil (Cellcept) is not known to cause hyperglycemia.
Answered 3/11/2015
3.3k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question